StockWatch
·

MANAPPURAM FINANCE LTD.

BSE: 531213

P/L Snapshot

Q3 FY2026 · standalone

vs Q2 FY2026
Revenue
1.9K
+5.4%
Expenditure
1.4K
+7.0%
Net Profit
381.15
+1.4%
OPM %
69.20%
+0.57pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00712.571.4K2.1K2.9KQ1 FY2027Q3 FY2018Q4 FY2018Q1 FY2019Q2 FY2019Q3 FY2019Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026

Price Chart

Latest News

Board Meeting11 Aug, 4:41 pm

Manappuram Q1 FY27: PAT surges 341% YoY to ₹585 Cr as Asirvad MFI turns profitable

Manappuram Finance's consolidated PAT rose 341% YoY to ₹584.77 Cr (₹132.47 Cr a year ago) and 44% QoQ (₹404.79 Cr), on consolidated total income of ₹3,040.33 Cr (+34% YoY, +16% QoQ). Standalone PAT was ₹551.77 Cr, +41% YoY, on total income of ₹2,544.90 Cr (+46% YoY). Consolidated NPM expanded sharply to ~19.2% from ~5.9% a year ago and ~15.4% last quarter — the headline YoY jump is a base-effect story more than fresh margin expansion: Q1 FY26's PBT of just ₹101.52 Cr was depressed by a ₹437.27 Cr segment loss at Asirvad Microfinance, which has now swung to a ₹27.70 Cr segment profit. Stripping out the MFI swing, the core gold-loan segment — the business management itself credits for this print — grew PBT a steadier ~40% YoY (₹754.12 Cr vs ₹538.79 Cr) and ~44% QoQ, a cleaner read on underlying momentum than the raw 341% headline. Gold-loan segment assets grew to ₹71,422.79 Cr from ₹65,927.05 Cr sequentially (+8.3% QoQ), consistent with management's FY27 guidance for strong AUM growth backed by branch expansion; the filing doesn't disclose a standalone gold-loan yield figure, so the guided 17.5–18% yield band and credit-cost trajectory remain unverified from this document. A ₹125.25 Cr additional ECL provision (from a revised PD/LGD/EAD model at the standalone entity and Manappuram Home Finance) was a quarter-specific cost drag embedded in the print, partially offsetting the MFI recovery. On street expectations, published surprise trackers show the print landed close to consensus — roughly a +1.9% EPS beat against a ~2.9% revenue miss — an inline quarter rather than a blowout, despite the eye-catching YoY percentage. Against our pre-result preview (HOLD rating, ₹340 target, flagged profitability deterioration and rising impairments as the key risks after Q3 FY26's 15.9% QoQ profit decline), the quarter resolves that concern: profitability rebounded QoQ and YoY, and the MFI drag the street was watching for has reversed into a segment profit. The CEO-transition watch item is also now formalised — the board approved Ashish Singh's appointment as MD & CEO effective January 1, 2027, with V.P. Nandakumar continuing as MD/Chairperson till December 31, 2026 before moving to Non-Executive Chairperson, giving the market a defined succession timeline instead of open-ended uncertainty. The board also declared an interim dividend of ₹1/share and approved raising the borrowing limit to ₹1,00,000 Cr via NCDs/CPs/bonds, subject to shareholder approval — a capital-access move alongside the BC Asia preferential allotment (₹2,192.47 Cr equity + ₹548.11 Cr warrant call already received) that underpins the funding for branch expansion. Management's own framing — "maintained robust loan growth and stable asset quality" with Asirvad's "return to profitability" as a key driver, gold loans "playing a crucial role in supporting overall bank credit growth," while flagging gold-price volatility as a challenge navigated successfully — matches the numbers: gold segment PBT up ~40% YoY/44% QoQ, MFI segment swinging from a large loss to profit. No formal near-term guidance on FY27 ROE/NIM numbers is verifiable from this filing; management's long-term target (consolidated ROE above 15%) is unquantified against this quarter's print here.

11 Aug 2026, 04:41 pm

Corporate Events

DividendMANAPPURAM
2026
17Aug

₹1 / share

BSE Filing
Board MeetingMANAPPURAM
2026
12Aug

Board Meeting

The 34th Annual General Meeting (AGM) of the Members of the …

BSE Filing
Board MeetingMANAPPURAM
2026
11Aug

Board Meeting

The Board of Directors approved the Unaudited Standalone and…

BSE Filing
Board MeetingMANAPPURAM
2026
14Jul

Board Meeting

The Extra-Ordinary General Meeting (EGM) is scheduled to be …

BSE Filing
Board MeetingMANAPPURAM
2026
23Jun

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing
Board MeetingMANAPPURAM
2026
30Mar

Board Meeting

To consider and approve the borrowing program for the Financ…

BSE Filing
Board MeetingMANAPPURAM
2026
29Jan

Board Meeting

consider and approve the Unaudited Standalone and Consolidat…

BSE Filing
Board MeetingMANAPPURAM
2025
30Oct

Board Meeting

consider and approve the Unaudited Standalone, consider and …

BSE Filing
Board MeetingMANAPPURAM
2025
8Aug

Board Meeting

consider and approve the Unaudited Standalone, consider and …

BSE Filing
Board MeetingMANAPPURAM
2025
20Mar

Board Meeting

Consider and approve fund raising proposal

BSE Filing
Board MeetingMANAPPURAM
2024
5Nov

Board Meeting

considering and approving the financial results for the quar…

BSE Filing
Board MeetingMANAPPURAM
2024
19Mar

Board Meeting

Consider and approve Borrowing program and business plan for…

BSE Filing
DividendMANAPPURAM
2024
19Feb

₹0.9 / share

BSE Filing
Board MeetingMANAPPURAM
2024
7Feb

Board Meeting

Consideration and approval of Un Audited Consolidated and St…

BSE Filing
DividendMANAPPURAM
2023
24Nov

₹0.85 / share

BSE Filing
Board MeetingMANAPPURAM
2023
13Nov

Board Meeting

Consider and approve Unaudited Standalone & Consolidated Fin…

BSE Filing
Board MeetingMANAPPURAM
2023
10Nov

Board Meeting

Consider and approve Unaudited Consolidated and Standalone F…

BSE Filing
DividendMANAPPURAM
2023
23Aug

₹0.8 / share

BSE Filing